Pfizer CEO Bourla ‘Cautiously Optimistic’ About Tariffs, Pricing Policies

2025 Guidance Reaffirmed, Tariff Impacts Not Included

 
• By Mandy Jackson
  
Pharma product tariffs may be lower for US allies and higher for countries that are not, Bourla opined (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Earnings

More from Scrip